Vikas Yadav

- Platforms: MDVC, Revenue: US$ 140M

- People Leadership: 2 Associates as DRs

- Key Responsibilities: Defend mature portfolios Profitable growth strategy for Category creation portfolios

Collaborating with Country teams, Regional Medical affairs, SCM and Strategic access teams

Leverage Global team's accessibility to developed and developing markets, insights and tactics from other markets

Enable country / sub-regions to deliver on Commercial plan strategies and tactics

Tracking Price increase and SGP improvement opportunities in FY25

- Key contributions:

YTD growth @ 17% Revenue and 45% OIBT

o Pricing: YTD Ach $5.1M @ 138%, Annual budget $4.5

o Price Governance SOP, completed for BD India

o Driving profitable growth, BDWoM in action: Executed Segmentation for Hospitals and Channel, Buying process for Safety portfolio, Benefit Ladder and Value offer for Patient safety and HCW safety portfolios, Account churn determining Loyalists and Defectors

o Sales Force Effectiveness: SFDC opportunity funnel (Funnel velocity, Pipeline Coverage Ratio), Competition profiles through KINDLEApp,

o Digital Strategy: Omnichannel approach – Social media marketing, Email marketing(Marketo), Lead magnet, online Registrations through Webinars / Global meet, Fulcrum App for VAM audits, VAR App for Channel engagement, Lead generation / Email marketing through Marketo

o Biz case and transfer of AD Syringes (200M units) line from FRAGA to BAWAL, India.

o Launch of Biopsy and V Mueller portfolios and transition to BDI Team

• Led cross-functional teams to implement strategic initiatives: FAB model for Phaseal and EPMO for transitioning to Phaseal Optima.
• Delivered Funnel management tracking training programs, improving Sales associates confidence, promote Phaseal Optima to Prep and Admin stakeholders.
• Competitive benchmarking against Equashield and ICU Medical for enhanced market competitiveness.
• Exploration of DVO and 'Dirty 20' list of high value drugs for effective targeting of Onco accounts

• Key Responsibilities:
• - Platforms: CCMD, VAD, IPD and GSD, Revenue: US$ 70M
• - People Leadership: 6 Associates as DRs (Promoted – 04, Lateral – 02)
• - Key Responsibilities: Profitable growth strategy, execution through 250 member Sales & Clinical teams
• Key contributions:
• O YTD growth @ 17% Revenue and 45% OIBT
• O Pricing: YTD Ach $5.1M @ 138%, Annual budget $4.5
• O Price Governance SOP, completed for BD India
• O Driving profitable growth, BDWoM in action: Executed Segmentation for Hospitals and Channel, Buying process for Safety portfolio, Benefit Ladder and Value offer for Patient safety and HCW safety portfolios, Account churn determining Loyals and Defectors
• O Sales Force Effectiveness: SFDC opportunity funnel (Funnel velocity, Pipeline Coverage Ratio), Competition profiles through KINDEL App
• O Digital Strategy: Omnichannel approach – Social media marketing, Email marketing (Marketo), Lead magnet, online Registrations through Webinars / Global meet, Fulcrum App for VAM audits, VAP for Channel engagement, Lead generation / Email marketing through Marketo
• O Biz case and transfer of AD Syringes (200M units) line from FRAGA to BAWAL, India.
• O Launch of Biopsy and V Mueller portfolios and transition to BDI Team

• Key Responsibilities:
• - P&L ownership for S1MM Sterilization & Disinfection portfolios, CAGR growth of 32% from 2013 to 2015
• - People Leadership: 30 member Sales, Marketing, Technical Service and Clinical team promoting Capital equipment (STERRAD) and Consumables
• - Technology Enabled growth: Validation for minimally invasive surgical devices, sensitive to high temperature sterilization with STERRAD sterilization systems
• - Business Models: Life cycle management and upgrade through Financial modeling, Hub-n-Spoke, Try-N-Buy and Pay per Use.
• - Technical Service: Formalized a dedicated call center and Service team to improve the uptime rate by 85% for 400 installations in South Asia
• - Customer Centricity: Launched Science of Terminal Sterilization, a program to educate, engage and train the key stakeholders in CSSD and OR.
• - Cross Culture experience: Part of APAC (Regional Leadership team) RLT and India CLT (Commercial Leadership Team)

• Key Responsibilities:
• - Application development in industries across Medical Packaging, Automobile, Pharmaceutical, Steel & Forging, with Dupont Tyvek and Nomex for South Asia Market
• - Six Sigma approach for product development, following Global Product stewardship norms
• - Revenue delivery – US$ 2M

• Key Responsibilities & Deliverables: Sales operations, Revenue delivery, Receivables, forecasting through People management

• Key Responsibilities & Deliverables: Sales operations, Revenue delivery, Receivables, forecasting through People management